Elevate connects innovative medical knowledge with didactics.

Metadeq, Inc. is committed to delivering diagnostics that help physicians identify, diagnose, stage and monitor MASLD and MASH patients with a simple and accurate blood test.

Metadeq’s lead product is HeparDx™, a blood test based on two biomarkers to detect MASH activity and liver fibrosis. This novel blood test is designed to improve accuracy of current non-invasive tests and can be used to: detect MASH in clinical practices, improve clinical trial screen failure rates, and monitor patient response to therapy.

Clinical data from a prospective study in 250 patients undergoing liver biopsies has been peer-reviewed and published in Gut, a leading medical journal.